Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth O Hexner

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Blood|December 3, 2011
AUF-1 and YB-1 are critical determinants of β-globin mRNA expression in erythroid cellsSebastiaan van Zalen, Grace R Jeschke, Elizabeth O Hexner, et al.
The American Journal of Emergency Medicine|June 21, 2016
Bilateral facial paralysis in a non-Hodgkin lymphoma during remission period: a rare but an important condition to be investigatedJuan M Bugueno, Benjamin E Jacobs, Elizabeth O Hexner, et al.
The American Journal of Medicine|August 24, 2014
A common, under-recognized cause of elevated serum erythropoietinDaria V Babushok, David Cardamone, Nichole Rulander, et al.
Nature Medicine|November 13, 2012
Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathwaysJian Huang, Michelle Nguyen-McCarty, Elizabeth O Hexner, et al.
Mechanisms of Development|February 28, 2015
AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding proteinSebastiaan van Zalen, Alyssa A Lombardi, Grace R Jeschke, et al.
Leukemia & Lymphoma|December 11, 2012
Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune diseaseCourtney D DiNardo, Alexis Ogdie, Elizabeth O Hexner, et al.
Transplantation and Cellular Therapy|November 27, 2024
Inconsistent Reporting and Definitions of Time-to-Event Endpoints in CAR T Clinical Trials: A ReviewConnor B Grady, Yimei Li, Shannon L Maude, et al.
Leukemia|August 9, 2018
Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32Daria V Babushok, Natasha L Stanley, Jennifer J D Morrissette, et al.
American Journal of Hematology|April 12, 2022
Salvage therapy with basiliximab and etanercept for severe steroid-refractory acute graft-versus-host diseaseCraig W Freyer, Shannon Gier, Alison Carulli, et al.
Haematologica|September 3, 2016
The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studiesVikas Gupta, Claire Harrison, Elizabeth O Hexner, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Blood|December 3, 2011
AUF-1 and YB-1 are critical determinants of β-globin mRNA expression in erythroid cellsSebastiaan van Zalen, Grace R Jeschke, Elizabeth O Hexner, et al.
The American Journal of Emergency Medicine|June 21, 2016
Bilateral facial paralysis in a non-Hodgkin lymphoma during remission period: a rare but an important condition to be investigatedJuan M Bugueno, Benjamin E Jacobs, Elizabeth O Hexner, et al.
The American Journal of Medicine|August 24, 2014
A common, under-recognized cause of elevated serum erythropoietinDaria V Babushok, David Cardamone, Nichole Rulander, et al.
Nature Medicine|November 13, 2012
Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathwaysJian Huang, Michelle Nguyen-McCarty, Elizabeth O Hexner, et al.
Mechanisms of Development|February 28, 2015
AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding proteinSebastiaan van Zalen, Alyssa A Lombardi, Grace R Jeschke, et al.
Leukemia & Lymphoma|December 11, 2012
Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune diseaseCourtney D DiNardo, Alexis Ogdie, Elizabeth O Hexner, et al.
Transplantation and Cellular Therapy|November 27, 2024
Inconsistent Reporting and Definitions of Time-to-Event Endpoints in CAR T Clinical Trials: A ReviewConnor B Grady, Yimei Li, Shannon L Maude, et al.
Leukemia|August 9, 2018
Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32Daria V Babushok, Natasha L Stanley, Jennifer J D Morrissette, et al.
American Journal of Hematology|April 12, 2022
Salvage therapy with basiliximab and etanercept for severe steroid-refractory acute graft-versus-host diseaseCraig W Freyer, Shannon Gier, Alison Carulli, et al.
Haematologica|September 3, 2016
The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studiesVikas Gupta, Claire Harrison, Elizabeth O Hexner, et al.
Pageof 11